Long Versus Short Axis Approach for Ultrasound Guided Peripheral Intravenous Access

Overview

To compare a long axis approach versus short axis when placing peripheral IVs using ultrasound guidance.

Full Title of Study: “Long Versus Short Axis Approach for Ultrasound Guided Peripheral Intravenous Access: A Randomized Control Trial”

Study Type

  • Study Type: Interventional
  • Study Design
    • Allocation: Randomized
    • Intervention Model: Parallel Assignment
    • Primary Purpose: Treatment
    • Masking: None (Open Label)
  • Study Primary Completion Date: July 1, 2024

Detailed Description

Patients needing an USGPIV will be randomized into long or short axis orientation. Emergency Medicine residents will place the IV using an ultrasound.

Interventions

  • Procedure: Intravenous access method
    • Comparing long and short axis approach to USGPIV access.

Arms, Groups and Cohorts

  • Active Comparator: Long Axis approach
    • Utilize the longitudinal orientation when placing an USGPIV.
  • Active Comparator: Short axis approach
    • Utilize the transverse orientation when placing an USGPIV.

Clinical Trial Outcome Measures

Primary Measures

  • First pass success
    • Time Frame: 1 day
    • USGPIV access
  • Number of attempts
    • Time Frame: 1 day
    • USGPIV access
  • Overall success
    • Time Frame: 1 day
    • USGPIV access
  • Time to completion
    • Time Frame: 1 day
    • USGPIV access

Secondary Measures

  • Complications
    • Time Frame: 1 day
    • USGPIV access

Participating in This Clinical Trial

Inclusion Criteria

  • Hemodynamically stable patients requiring placement of an USGPIV. Exclusion Criteria:

  • Hemodynamically unstable – Unable to consent

Gender Eligibility: All

Minimum Age: 18 Years

Maximum Age: 99 Years

Are Healthy Volunteers Accepted: No

Investigator Details

  • Lead Sponsor
    • Temple University
  • Provider of Information About this Clinical Study
    • Principal Investigator: Ryan Gibbons, Assistant Professor of Emergency Medicine – Temple University
  • Overall Official(s)
    • Ryan C Gibbons, MD, Principal Investigator, Temple University
  • Overall Contact(s)
    • Ryan C Gibbons, MD, 6106137408, ryan.gibbons@tuhs.temple.edu

Clinical trials entries are delivered from the US National Institutes of Health and are not reviewed separately by this site. Please see the identifier information above for retrieving further details from the government database.

At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.